SB China Venture Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
6

- Investments
-
276
- Portfolio
-
149
- Exits
-
59

SB China Venture Capital General Information
Description
Established in 2000, SB China Venture Capital (SBCVC) is a venture capital and private equity firm headquartered in Shanghai, China. The firm focuses on high-tech, high growth companies in TMT, clean technology, healthcare, consumer, retail, and advanced manufacturing sectors and invest across all stages of companies.
Contact Information
Website
www.sbcvc.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Corporate Venture Capital
PE/Buyout
Primary Office
- Block A-C, 15th Floor, Huamin Hanzun International
- No. 728 Yan'an West Road, Changning District
- Shanghai, 200050
- China
+86 00000000000
SB China Venture Capital Investments (276)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
Lasic | 17-Nov-2022 | Secondary Transaction - Private | Electrical Equipment | Generating Revenue | ||
00000 0000000 | 26-Oct-2022 | 00 000000000 | 000.00 | Business/Productivity Software | Generating Revenue | |
00 00000 | 28-Jul-2022 | 00000 00000 | Automotive | Startup | ||
000000 | 25-Jul-2022 | 00000 00000 | Biotechnology | Generating Revenue | ||
000 0000000 000000 | 01-Jul-2022 | 00000 00000 | Surgical Devices | Generating Revenue | ||
0000000 0000000000 | 01-Apr-2022 | 00000 00000 | General Purpose Semiconductors | Generating Revenue | ||
00000000 0000000 0 | 17-Mar-2022 | 00000 00000 | 000.00 | Operating Systems Software | Generating Revenue | |
00000000 | 11-Feb-2022 | 00000 00000 | Fiberoptic Equipment | Generating Revenue | ||
Heli Lian | 26-Jan-2022 | Later Stage VC | 00.00 | Business/Productivity Software | Profitable | |
Tsingke Biotechnology | 19-Jan-2022 | Early Stage VC | 000.00 | Biotechnology | Generating Revenue |
SB China Venture Capital Exits (59)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Dingdang Kuaiyao | 13-Sep-2022 | IPO | 000.00 |
0000000 000000 | 05-Aug-2022 | 000000000 00000000 | |
0000000 00000 | 26-Dec-2021 | 000 | 00000 |
0000000 | 15-Aug-2021 | 000 00 00000000 | |
000000000 | 26-Jan-2021 | 000 00 00000000 | |
00000 | 03-Dec-2020 | 000000000000000000 | |
00000000 | 02-Dec-2020 | 000 00 00000000 | |
0-000000 | 26-Aug-2020 | 000 00 00000000 | |
VeriSilicon | 17-Aug-2020 | IPO | 00000 |
Quhuo Tech Company | 10-Jul-2020 | IPO | 0000 |
SB China Venture Capital Fund Performance
Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
---|
SB China Venture Capital Investments by Industry, Year, and Region
SB China Venture Capital Team (10)
Name | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Kathy Chen | Managing Partner & Chief Financial Officer | 0 | 0 | 0 | Shanghai, China |
Amy Yeh | Senior Managing Director | Shanghai, China | |||
Chauncey Shey Ph.D | Founder & Co-Managing Partner | 0 | 0 | 0 | Shanghai, China |
Anlan Song Ph.D | Co-Managing Partner | 0 | 0 | 0 | Shanghai, China |
Ping Hua Ph.D | Co-Managing Partner | 0 | 0 | Shanghai, China |
SB China Venture Capital Co-Investors (176)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Hillhouse Capital Group | 4 |
![]() |
![]() |
||
5Y Capital | 0 |
![]() |
![]() |
||
Cowin Capital | 0 | 0 | 0 |
![]() |
![]() |
Shenzhen Capital Group | 0 |
![]() |
![]() |
||
GGV Capital | 0 | 0 |
![]() |
![]() |